Printer Friendly

WILSHIRE TECHNOLOGIES RECEIVES FDA 510(K) APPROVAL FOR INNOVATIVE DERMASSIST(TM) TRANSPARENT SITE DRESSING

 LA JOLLA, Calif., Feb. 10 /PRNewswire/ -- Wilshire Technologies Inc. (NASDAQ: WITE) today announced that it has received 510(k) approval from the FDA for its innovative DermAssist(TM) Transparent Site Dressing, manufactured and marketed by its Wilshire Medical Products division.
 This is the first in a series for the DermAssist(TM) family of IV site and wound dressings.
 The DermAssist(TM) Transparent Site Dressing is a thin, transparent polyurethane film that acts as a barrier to moisture and bacteria, yet is permeable to moisture vapor and oxygen. The product may be used to secure IV devices, as well as a dressing for superficial pressure ulcers, skin grafts, donor sites and reduction of friction.
 Wilshire Technologies made its initial public offering of common stock in November 1992. The company develops, manufactures and markets disposable products for medical and clean room use through its subsidiaries, Wilshire Medical Products and Wilshire Contamination Control. The company has focused on proprietary products that incorporate its engineered materials, acquired polyurethane and other technologies and its expertise in materials fabrication.
 -0- 2/10/93
 /CONTACT: Michael Crow, 619-456-9400, or John Keener, 800-234-8132, both of Wilshire Technologies/
 (WITE)


CO: Wilshire Technologies Inc.; Wilshire Medical Products ST: California IN: MTC SU:

MS-BP -- SD004 -- 5192 02/10/93 13:04 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 10, 1993
Words:211
Previous Article:PHILADELPHIA BANKERS BUCK THE TREND; SET ALL-TIME RECORD PROVIDING HOME MORTGAGE LOANS TO LOW- AND MODERATE-INCOME COMMUNITIES
Next Article:MICROSCOPIC MAP-MAKING A MAJOR PART OF ORNL'S GENOME PROGRAM
Topics:


Related Articles
WILSHIRE TECHNOLOGIES SETS INTERNATIONAL SALES PACT FOR ITS ADVANCED DISPOSABLE MEDICAL PRODUCTS
NEW MATERIALS MAKE OLD PRODUCTS BETTER, SAFER, MORE EFFECTIVE
WILSHIRE MEDICAL PRODUCTS HIRES WOUND HEALING EXPERT AS MEDICAL/CLINICAL DIRECTOR
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES FDA MARKETING CLEARANCE FOR SHOULDER THERAPY DEVICE
DANNINGER MEDICAL TECHNOLOGY, INC. SUBSIDIARY RECEIVES FDA MARKET CLEARANCE FOR ANTERIOR PORTION OF SYNERGY SYSTEM
FUTURE MEDICAL PRODUCTS ANNOUNCES FDA MARKETING CLEARANCE OF EECP
BIOCONTROL SAYS FDA PROCESS FOR NONINVASIVE GLUCOSE SENSOR MOVES FORWARD
BIOCONTROL TECHNOLOGY, INC. MEETS WITH THE FDA
QUEST MEDICAL REPORTS FDA CLEARANCE OF 510(K) SUBMISSION FOR THE MPS MYOCARDIAL PROTECTION SYSTEM
POSSIS MEDICAL FILES 510(k) AND IDE APPLICATIONS AND RECEIVES SECOND U.S. PATENT FOR ANGIOJET RAPID THROMBECTOMY SYSTEM

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters